link to homepage

Institute of Neuroscience and Medicine

Navigation and service


The institute focus on research fields that require the use of nuclear methods. These are in particular the development of new radiotracers for the in vivo imaging using  Positron Emission Tomography (PET) or Single Photon Emission Computed Tomography (SPECT). The potential of these imaging techniques are in the noninvasive diagnostic of regional physiological dysfunctions before the disease is manifested morphologically in order to start with therapeutic actions at an early stage

Zyklotron komplett

Radionuclide development

Beside the routine production of radiopharmaceuticals not-standard-PET-Nuclide are also produced for research purposes. More: Radionuclide development …


For a few years the development of radiolabelled compounds has been focusing on visualization of physiological processes in the central nervous system. Receptors and enzymes represent the most important macromolecular targets. The principal task of the research group "radiopharmacology" consists of the characterization of novel ligands. More: Radiopharmacology …

Radiotracer development

A prerequisite for the syntheses of radiotracers for the positron-emission-tomography is the development of new methods for the introduction of the very low amounts (<10-9 g) of a radionuclide (e.g. fluorine-18, carbon-11) into organic molecules in a shorter time scale. More: Radiotracer development …

Synthese in der Produktion

Radiotracer production

The representative focus of research of this group is on the development of "small molecule" ligands particularly for the adenosinergic system with the aim of non-invasive imaging of interesting biological targets with PET and SPECT using suitable radiolabelled derivatives. More: Radiotracer production …